Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

This study has been completed.
The 4C trial bureau
Japan Heart Foundation
Information provided by (Responsible Party):
Hisao Ogawa, Kumamoto University Identifier:
First received: August 29, 2005
Last updated: April 17, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)